Skip to content

Author

Xiaolin Cui

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Biomimetic inhalable nanovesicles for enhanced cardiac therapy of heart failure following myocardial infarction.

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, and myocardial infarction (MI) frequently progresses to heart failure despite advances in contemporary therapies. A major barrier to the clinical translation of cardioprotective biologics is the lack of noninvasive, organ-targeted delivery...

Xi-Qing Zhao, Ke-Dong Hu, Zhen Qin et al. · 0 citations
Review Jul 2026

The long shadow: a toxicological review of chronic exposure, biopersistence, and latent health risks of engineered nanomaterials.

An integrated risk assessment framework is proposed that combines adverse outcome pathway analysis, physiologically-based pharmacokinetic modeling, new approach methodologies, and safe-by-design principles to enable predictive hazard identification and supports evidence-based regulation of existing ENMs while enabling...

Yu-Jian Fan, Jiaying Lyu, Xiao-Kai Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.